Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

386
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
386
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

3.9K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
3.9K
Inflammatory Response01:28

Inflammatory Response

15.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.8K
T Cell Types and Functions01:24

T Cell Types and Functions

2.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

422
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
422
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

316
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
316

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sympathosensory interactions - Possible relevance in osteoarthritis.

Osteoarthritis and cartilage·2025
Same author

Exosomes and microRNA - a new form of remote and bidirectional neuroimmunomodulation?

Neuroimmunomodulation·2025
Same author

In Memoriam: Alfonse T. Masi, MD.

Neuroimmunomodulation·2025
Same author

A History of Psycho-Neuro-Endocrine Immune Interactions in Rheumatic Diseases.

Neuroimmunomodulation·2024
Same author

β2-adrenoceptors kick osteoarthritis - Time to rethink prevention and therapy.

Osteoarthritis and cartilage·2024
Same author

Letter to the editor.

Brain, behavior, and immunity·2024

Related Experiment Video

Updated: Jan 4, 2026

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
08:56

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue

Published on: May 17, 2018

9.5K

Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms.

S Mechiel Korte1,2, Rainer H Straub3

  • 1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, (UIPS), Utrecht University, Utrecht, The Netherlands.

Rheumatology (Oxford, England)
|November 5, 2019
PubMed
Summary

Inflammatory rheumatic disorders cause persistent fatigue through complex pathophysiological mechanisms. Proinflammatory cytokines and oxidative stress disrupt neurotransmitter balance, impacting brain function and leading to fatigue.

Keywords:
fatigueinflammationmechanismspathophysiologyrheumatic disorders

More Related Videos

The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model
05:38

The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model

Published on: April 12, 2024

537
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

927

Related Experiment Videos

Last Updated: Jan 4, 2026

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
08:56

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue

Published on: May 17, 2018

9.5K
The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model
05:38

The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model

Published on: April 12, 2024

537
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

927

Area of Science:

  • Neuroscience
  • Immunology
  • Rheumatology

Background:

  • Rheumatic disorders are treatable, yet residual fatigue persists in many patients.
  • Understanding the mechanisms of fatigue is crucial for improving patient outcomes.

Purpose of the Study:

  • To elucidate the pathophysiological mechanisms underlying fatigue in inflammatory rheumatic disorders.
  • To identify key molecular and cellular pathways contributing to persistent fatigue.

Main Methods:

  • Review of current literature on cytokine signaling and neurotransmitter metabolism.
  • Analysis of the impact of chronic inflammation on monoaminergic and glutamatergic systems.
  • Investigation of the role of oxidative stress and astrocyte function in fatigue.

Main Results:

  • Proinflammatory cytokines disrupt neurotransmitter release and increase monoamine breakdown.
  • Oxidative stress and increased indoleamine-2,3-dioxygenase activity reduce serotonin availability.
  • Astrocytes contribute to fatigue by inhibiting neurotransmitter transporters and producing kynurenic acid, which reduces dopamine release.

Conclusions:

  • Fatigue in rheumatic disorders stems from complex interactions between inflammation, oxidative stress, and neurotransmitter dysregulation.
  • These mechanisms collectively impair brain function in fatigue-related areas.
  • Targeting these pathways may offer novel therapeutic strategies for managing fatigue.